Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement

NCT02952573 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Low patient accrual

Conditions

Multiple Myeloma
Relapsed/Refractory

Interventions

DRUG: JNJ-42756493
DRUG: Dexamethasone

Sponsor

University Health Network, Toronto

Collaborators

[object Object]